Obesity linked to higher risk of kidney stones

January 18, 2010 — NEW YORK (Reuters Health) - Obese people are more likely to develop kidney stones than normal weight individuals, but severe obesity doesn't seem to further increase risk, research in the Journal of Urology shows.

Robot prostate surgery has downsides, needs more data

January 11, 2010 — NEW YORK (Reuters Health) - Considering having a surgeon remove your cancerous prostate using a robot? You might want to see a surgeon who has done at least 80 operations for the best results, according to the authors of a new research review.

Exercise may prevent incontinence from prostate surgery

January 7, 2010 — NEW YORK (Reuters Health) - A healthy weight and regular exercise may help protect men from one of the most common side effects of prostate cancer surgery, a new study suggests.

Blood in the urine? Check with a microscope

December 28, 2009 — NEW YORK (Reuters Health) - When a dipstick test suggests there's blood in the urine, the next step should be to examine a sample of the urine under a microscope to make sure the dipstick result is accurate, according to medical guidelines - but often the patient is sent directly to see a specialist, or for further testing.

Many prostate cancers caught by screening won't kill

December 4, 2009 — NEW YORK (Reuters Health) - The number of prostate cancers diagnosed in UK men each year would jump from 30,000 to 160,000 if the country introduced population-wide screening for the disease, new research shows. However, many of those cancers are low-risk and may not lead to death.

Moderate exercise may lower prostate cancer risk

November 6, 2009 — NEW YORK (Reuters Health) - Men who regularly get moderate exercise may have a lower risk of developing prostate cancer -- including aggressive, fast-growing tumors, a new study finds.

Long-term risks of Viagra use unclear

October 8, 2009 — NEW YORK (Reuters Health) - The popular erectile dysfunction drug Viagra is associated with a number of side effects, but data on long-term harms are still lacking, according to a review of 49 published studies.

Moderate exercise may lower prostate cancer risk

September 29, 2009 — NEW YORK (Reuters Health) - Ready for another reason to exercise? Men who exercise at even moderate levels may have a lower risk of prostate cancer than sedentary men, a new study suggests.

Men with rare gender disorder can still have kids

September 18, 2009 — NEW YORK (Reuters Health) - Men with a rare disorder in which they carry extra female genes can still have children if they undergo a surgical procedure for collecting their sperm, according to a new study.

Medical societies push standards for robotic surgery

September 18, 2009 — CHICAGO (Reuters) - Surgeons are increasingly turning to high-tech robotic equipment to operate on patients with prostate cancer and other conditions, but some medical authorities worry about inadequate training and lax standards among practitioners.

Prostate size does not affect results of surgery

September 11, 2009 — NEW YORK (Reuters Health) - Prostate size affects the technical difficulty of radical prostatectomy -- total surgical removal of the prostate gland as a treatment for prostate cancer -- but not the functional results, according to researchers at Memorial Sloan-Kettering Cancer Center in New York.

Similar outcomes for new and old prostate surgeries

September 9, 2009 — NEW YORK (Reuters Health) - If you've decided that a surgeon should remove your prostate and you're trying to figure out which kind of surgery is best, a new study may assure you that traditional techniques perform just as well as newer techniques.

Gastric bypass may raise risk of kidney stones

June 30, 2009 — NEW YORK (Reuters Health) - The risk of kidney stone disease and kidney stone surgery is increased following gastric bypass surgery that is performed to treat morbid obesity, according to a study published in the Journal of Urology.

NSAIDs may interfere with prostate cancer diagnosis

June 23, 2009 — NEW YORK (Reuters Health) - Frequently used, over-the-counter drugs referred to as "nonsteroidal anti-inflammatory drug," (NSAIDs), such as aspirin, ibuprofen and others, may interfere with the early diagnosis of prostate cancer, according to Tennessee-based researchers.

Agent Orange worsens prostate cancer prognosis

May 1, 2009 — NEW YORK (Reuters Health) - Among Vietnam veterans who have undergone major prostate cancer surgery, those who were exposed to Agent Orange have an increased risk of an aggressive recurrence, according to results of a study appearing in the British Journal of Urology (BJU) International.